| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 427,2 k € | +23.9% | 344,9 k € | +20.2% | 286,9 k € | +1.2% | 283,4 k € | +4.0% | 272,6 k € | -41.2% | 463,5 k € | +18.4% | 391,7 k € | +38.6% | 282,6 k € | +110.1% | 134,5 k € | +44.6% | 93,0 k € | -38.1% | 150,1 k € | -53.1% | 319,9 k € | +54.2% | 207,4 k € | -1.4% | 210,5 k € | +16.8% | 180,2 k € | +8.4% | 166,3 k € | +43.5% | 115,9 k € | +53.0% | 75,7 k € | |
| EBITDA | 386,4 k € | +24.6% | 310,2 k € | +25.1% | 248,0 k € | -2.3% | 253,8 k € | +0.5% | 252,6 k € | -43.9% | 450,1 k € | +17.0% | 384,6 k € | +38.8% | 277,0 k € | +116.2% | 128,1 k € | +46.5% | 87,4 k € | -39.4% | 144,3 k € | -42.1% | 249,2 k € | +26.5% | 197,0 k € | -4.1% | 205,3 k € | +20.5% | 170,4 k € | +3.6% | 164,4 k € | +43.7% | 114,5 k € | +59.2% | 71,9 k € | |
| Operating profit | 336,8 k € | +30.3% | 258,4 k € | +31.0% | 197,3 k € | -32.2% | 291,1 k € | +29.0% | 225,6 k € | -46.8% | 424,1 k € | +18.8% | 357,1 k € | +46.2% | 244,3 k € | +170.7% | 90,2 k € | +175.8% | 32,7 k € | -69.2% | 106,1 k € | -38.6% | 172,8 k € | +6.5% | 162,2 k € | -5.1% | 170,8 k € | +22.5% | 139,4 k € | +2.5% | 136,0 k € | +52.8% | 89,0 k € | +113.6% | 41,7 k € | |
| Profit/loss | 234,7 k € | +21.0% | 193,9 k € | +26.1% | 153,8 k € | -53.2% | 328,5 k € | +108.7% | 157,4 k € | -42.4% | 273,1 k € | +11.8% | 244,4 k € | +68.5% | 145,1 k € | +161.3% | 55,5 k € | +67.2% | 33,2 k € | -38.8% | 54,3 k € | -43.0% | 95,2 k € | +20.9% | 78,7 k € | -13.4% | 90,9 k € | +11.8% | 81,3 k € | +22.6% | 66,3 k € | +62.2% | 40,9 k € | +182.7% | 14,5 k € | |
| Equity | 2,3 M € | +11.4% | 2,1 M € | +10.4% | 1,9 M € | +9.0% | 1,7 M € | +12.6% | 1,5 M € | +11.5% | 1,4 M € | +25.0% | 1,1 M € | +28.9% | 846,0 k € | +44.4% | 585,8 k € | +10.5% | 530,3 k € | +6.7% | 497,1 k € | +3.7% | 479,3 k € | +19.5% | 401,2 k € | +12.2% | 357,4 k € | +12.9% | 316,6 k € | +11.0% | 285,3 k € | +30.3% | 218,9 k € | +23.0% | 178,0 k € | |
| Total assets | 2,5 M € | +12.2% | 2,2 M € | +9.1% | 2,0 M € | +6.6% | 1,9 M € | +5.5% | 1,8 M € | +8.3% | 1,7 M € | +17.9% | 1,4 M € | +22.9% | 1,2 M € | +25.5% | 922,5 k € | +3.0% | 895,9 k € | -29.6% | 1,3 M € | +38.9% | 915,6 k € | +6.0% | 863,7 k € | -1.4% | 875,7 k € | +6.6% | 821,3 k € | +6.9% | 768,4 k € | +8.4% | 708,7 k € | +16.8% | 606,6 k € | |
| Cash | 51,0 k € | -47.4% | 96,9 k € | +244.7% | 28,1 k € | -70.8% | 96,4 k € | -82.8% | 560,5 k € | -2.5% | 575,1 k € | +36.9% | 420,2 k € | +127.8% | 184,5 k € | +309.9% | 45,0 k € | +94959.6% | 47,3 € | -93.2% | 700,5 € | — | 4,0 k € | -95.6% | 90,5 k € | +34.5% | 67,3 k € | +219.4% | 21,1 k € | +54.9% | 13,6 k € | -40.1% | 22,7 k € | |||
| Debts | 209,3 k € | +21.4% | 172,5 k € | -4.0% | 179,7 k € | -12.8% | 205,9 k € | -10.3% | 229,6 k € | -6.8% | 246,4 k € | -7.0% | 265,0 k € | +8.3% | 244,6 k € | -9.1% | 269,2 k € | -10.2% | 299,6 k € | -57.8% | 710,0 k € | +94.0% | 366,0 k € | -19.8% | 456,6 k € | -10.9% | 512,3 k € | +3.9% | 492,9 k € | +4.6% | 471,3 k € | -2.6% | 483,9 k € | +14.5% | 422,7 k € | |
Private company with limited liability · Gerpinnes · incorporated on 21/08/2001
Private company with limited liability profitable and well capitalised. Cash position declining (-47.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CABINET MEDICAL DOCTEUR PAUL JONARD is a Private company with limited liability incorporated in 2001. Its main activity is: Specialist medical practice activities. Its registered office is in Gerpinnes.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette